
2012.5 |
SCLABA®-Realに関する論文が Tanaka, A., Amagai, Y., Oida, K., and Matsuda, H. (2012) Recent findings in mouse models for human atopic dermatitis. Exp. Anim. 61(2):77-84. |
2011.9 |
GAIT®が使用された論文が Okamoto, N., Tanaka, A., Jung K., Karasawa, K., Orito, K., Matsuda, A., Amagai, Y., Oida, K., Ohmori, K., and Matsuda, H. (2011) Silencing of int6 gene restores function of the ischaemic hindlimb in a rat model of peripheral arterial disease. Cardiovasc. Res. 92(2):209-217. |
2011.9 |
SCLABA®-Realが使用された論文が Jung, K., Tanaka, A., Fujita, H., Matsuda, A., Oida, K., Karasawa, K., Okamoto, N., Ohmori, K., Jee, Y., Shin, T., and Matsuda, H. (2010) Peroxisome proliferator-activated receptor γ-mediated suppression of dendritic cell function prevents the onset of atopic dermatitis in NC/Tnd mice. J. Allergy Clin. Immunol. 127(2):420-429. |
2010.11 |
SCLABA®-Realが使用された論文が Moniaga, C.S., Egawa, G., Kawasaki, H., Hara-Chikuma, M., Honda, T., Tanizaki, H., Nakajima, S., Otsuka, A., Matsuoka, H., Kubo, A., Sakabe, J., Tokura, Y., Miyachi, Y., Amagai, M., and Kabashima, K. (2010) Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract. Am. J. Pathol. 176(5):2385-2393. |
2010.11 |
SCLABA®-Realが タイトル:特集 痒みのメカニズム アップデート II. 動物モデルと痒みの評価・測定法 |
2010.11 |
SCLABA®-Realが使用された論文が Hattori, K., Nishikawa, M., Watcharanurak, K., Ikoma, A., Kabashima, K., Toyota, H., Takahashi, Y., Takahashi, R., Watanabe, Y., and Takakura, Y. (2010) Sustained exogenous expression of therapeutic levels of IFN-γ ameliorates atopic dermatitis in NC/Nga mice via Th1 polarization. J. Immunol. 184(5):2729-2735. |
2010.11 |
GAIT®が使用された論文が Orito, K., Kurozumi, S., Ishii, I., Tanaka, A., Sawada, J., and Matsuda, H. (2007) A sensitive gait parameter for quantification of arthritis in rats. J. Pharmacol. Sci. 103(1):113-116. |
2010.11 |
SCLABA®が使用された論文が Orito, K., Chida, Y., Fujisawa, C., Arkwright, P.D., and Matsuda, H. (2004) A new analytical system for quantification scratching behaviour in mice. Br. J. Dermatol. 150(1):33-38. |
2009.12 |
SCLABA®が使用された論文が Tanaka, A., Jung, K., Benyacoub, J., Prioult, G., Okamoto, N., Ohmori, K., Blum, S., Mercenier, A., and Matsuda, H. (2009) Oral supplementation with Lactobacillus rhamnosus CGMCC 1.3724 prevents development of atopic dermatitis in NC/NgaTnd mice possibly by modulating local production of IFN-γ. Exp. Dermatol. 18(12):1022-1027. |
2008.3 |
SCLABA®が使用された論文が Tanaka, A., Fukushima, Y., Benyacoub, J., Blum, S., Mercenier, A., and Matsuda, H. (2008) Prophylactic effect of oral administration of Lactobacillus johnsonii NCC533 (La1) during the weaning period on atopic dermatitis in NC/NgaTnd mice. Eur. J. Dermatol. 18(2):136-140. |